Viewing Study NCT03771157

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2026-02-23 @ 4:10 AM
Study NCT ID: NCT03771157
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2018-12-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
Sponsor: University of Rochester
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia (CLL) View
None Waldenstrom Macroglobulinemia (WM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None shingles vaccine (Shingrix) View
None Chronic lymphocytic leukemia (CLL) View
None Waldenstrom macroglobulinemia (WM) View
None Pilot Study View